Renata Ferrari

Ropes & Gray - UNITED STATES


Renata Ferrari's competencies

Practice AreaJurisdictionRankAgg. Deals ValueClients DimensionN. of TransactionsLast Quarter
EmploymentUNITED STATES27275050752
Executive CompensationUNITED STATES4723670321121
Practice AreaJurisdictionRankAgg. Deals ValueClients DimensionN. of TransactionsLast Quarter
Showing 1 to 2 of 2 entries

Client Reviews

The Client Reviews provides a qualitative rating based on Partners' Clients feedback assessment


Communication Skills

0255075100Below expectationMeet expectationExceed expectation0

Technical skills

0255075100Below expectationMeet expectationExceed expectation0

Efficiency

0255075100Below expectationMeet expectationExceed expectation0


Effectiveness




Perceived Added Value

Ranking 2022: Renata Ferrari - Ropes & Gray

Practice AreaAgg. Deals ValueClients DimensionN. of TransactionsTier
Employment370038833
Executive Compensation24530326121
Practice AreaAgg. Deals ValueClients DimensionN. of TransactionsTier
Showing 1 to 2 of 2 entries

Ranking 2021: Renata Ferrari - Ropes & Gray

Practice Area Agg. Deals Value Clients Dimension N. of Transactions Tier
Employment902522205
Executive Compensation1414520009
Practice Area Agg. Deals Value Clients Dimension N. of Transactions Tier

Ranking 2020: Renata Ferrari - Ropes & Gray

Practice Area Agg. Deals Value Clients Dimension N. of Transactions Tier
Employment2358752
Executive Compensation9208327
Practice Area Agg. Deals Value Clients Dimension N. of Transactions Tier

Significant Clients

The chart shows a balanced list of the Renata J. Ferrari's client portfolio - based on PBV Monitor's Analyzed Transactions during last Twelve Mounths
Xerox Holdings CorpTD Securities USAStifel, Nicolaus & Company, IncorporatedSanofi VenturesKailera TherapeuticsGuggenheim SecuritiesGoldman Sachs & Co.G1 Therapeutics, Inc.Eversource EnergyEli Lilly and CompanyCAMP4 TherapeuticsBerkshire PartnersBain Capital Life SciencesBain Capital1440 Foods05K10KRevenue (ML. Euro)

Team

The chart shows a balanced list of counselor working with Renata J. Ferrari - based on PBV Monitor's analyzed transactions during last Twelve Mounths
Pamela GlazierPeter AlpertJonathan KlarfeldMegan BiskKellie CombsArthur MokAma AdamsThomas DanielskiSally DavisRuchit PatelRaymond GrantNicholas BergMichael McFallsMichael BeauvaisFran FairclothEric Behl-RemijanEdward McNicholasDervla BroderickDavid SaltzmanDavid KayeDavid HutchinsByung ChoiBrendanHanifinArek MaczkaZachary BlumeWilliamShieldsTimothyFarrellThomasHoldenThomasFraserTaylor HartTara FisherStefanieBirkmannScott RolnikScottPinarchickSarah YoungSamerMusallamRyan PrestonDahlRocky TsaiRichardGordetRegina SamPentiRajarshiBanerjeePeter WelshOliver NipNeill JakobeMelissaRonesMegan Baca MatthewByronMartin Crisp MarkoZatylnyMargaux HallMarcRubensteinLisaKaltenbrunnerLisa FolkerthKyle HigleyKatherineWangJoshuaTalicskaJoshuaOysterJoshuaLichtensteinJordanAltmanJessica ReeceJessicaCooneyJenniferCormierJanet CoscinoGregoryDemersGregoryDavisGiancarloLeeGeorginaJones SuzukiGeoffrey LinEve BruntsEvanTallmadgeErica HanEmilyOldshueEmilyKarlberg(Lieberman)ElaineMurphyDeidreJohnsonDavidMcIntoshDanielMcCaugheyDanielFreshmanDaniel CoyneConnie ShenCharles BoerBrynn RailBryanLowranceBrandon WinerBoxin WangAndrea DaleyAmanda HoltAlyceChenAlisonFethkeAbigailGregor03.68K7.37KAgg. deal value (ML. Euro)

Co-Counsel

The Chart shows a balanced list of Renata J. Ferrari's Co-Counsel Law Firm - based on PBV Monitor's analyzed transactions during last Twelve Mounths
Willkie Farr & Gallagher07501.5KAgg. deal value (ML. Euro)

Counterparts

The Chart shows a balanced list of Renata J. Ferrari's other Firms involved - based on PBV Monitor's analyzed transactions during last Twelve Mounths
Paul Hastings LLPSkaddenArentFox SchiffKirkland & EllisCravath Swaine & MoorePaul Weiss Rifkind Wharton & GarrisonDechert02.29K4.58KAgg. deal value (ML. Euro)

Peer Reviews

The Peer Reviews provides a qualitative rating based on Counterparts / Referees' feedback assessment



Recent experiences

Sanofi's $1.9 Billion Acquisition of Dren Bio’s Bispecific Antibody-Based Program3/28/2025
Sionna Therapeutics' $219.2 Million Upsized IPO2/13/2025
Berkshire Partners' Investment in Triumvirate Environmental2/7/2025
Aquarion Water Authority's $2.4 Billion Acquisition of Aquarion Water Company1/30/2025
Eli Lilly's $2.5 Billion Acquisition of Scorpion Therapeutics and its PI3Kα Cancer Program1/15/2025